Abiopharma

🔍 Dahl Andrew M. (Executive)

Company: Edwards Lifesciences Corp (EW)

Report Date: 2026-08-31

Detailed Transactions and Holdings:

• Sold 544 shares of Common Stock at $91.055 per share (Direct)
  Date: 2026-08-31 | Code: S | equity_swap_involved: 0 | shares_owned_after: 14,868.41 | transaction_form_type: 4

Footnotes:

• REMARKS: This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This Form 4 includes quarterly acquisition of shares under the Issuer's Employee Stock Purchase Plan.